首次扣押和符合商用汽车驾驶执照的资格
Nicholas Lawn1, Judy Lee2, John Dunne2,3
1Neurology, WA Adult Epilepsy Service, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia Nicholas.Lawn@health.wa.gov.au.
Journal of neurology, neurosurgery, and psychiatry
|June 26, 2024
概括
第一次发作后的驾驶限制可能需要重新评估. 即使没有风险因素,每年发作复发的风险仍然比目前的指导方针建议的时间更长.
科学领域:
- 神经学 神经学
- 的研究研究.
- 驾驶安全 驾驶安全 驾驶安全
背景情况:
- 目前的指导方针建议私人驾驶6个月无,商业驾驶执照 (CDL) 的标准更为严格.
- 首次发作后驾驶的CDL指南基于有限的数据,缺乏长期跟进.
- 对于私家车司机来说,经过6个月的发作自由后,每年发作复发的风险通常会降至20%以下.
研究的目的:
- 评估第一次发作后患者的长期发作复发风险.
- 为驾驶资格标准提供信息,特别是对于商业驾驶执照 (CDL) 持有者.
- 评估当前没有的时间是否足以安全恢复驾驶.
主要方法:
- 对1714名第一次发作的患者进行前性研究.
- 使用生存分析来评估发作复发率.
- 年度条件性发作复发风险是根据发作类型 (无诱发或急性症状) 和风险因素 (临床,EEG,神经成像) 计算的.
主要成果:
- 对于未引起的第一次发作,每年复发风险在9年内保持在2%以上.
- 即使没有EEG或神经成像异常,5年后每年风险为3.9%.
- 对于急性症状第一次发作,一年后的年风险为4.5%,仅在4年后才下降到2%以下.
结论:
- 比预期更高的每年发作复发风险持续超过目前推的无发作期,无论是未引起的还是急性症状的第一次发作.
- 这些发现表明,目前恢复驾驶的指导方针,特别是对于CDL持有人,可能需要修订.
- 数据支持在第一次扣押后关于驾驶资格的知情决策,考虑到长期复发风险.
更多相关视频
05:33A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
2.7K
11:12Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
17.4K
相关概念视频
Seizures: Classification
331
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
331
Narcolepsy
101
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
101
Antiepileptic Drugs: Potassium Channel Activators
168
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
168
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
285
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
285
Arteries of the Lower Limbs
186
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
186
